Overseed

📍 Orléans, France🗓 Founded 2021👥 24 employees💰 Last funded Jun 2024
Overseed is the first French biotech company to obtain its license from the ANSM to start its R&D process on cannabis production for pharmaceutical purposes. We are a Biotech which combines leading expertise in genetics, agronomy, organic chemistry and pharma with the ambition to have an expert knowledge on the production of therapeutic cannabis. We will produce GACP and GMP certified dried flowers, full spectrum extracts and purified pharmaceutical grade active ingredients for laboratories. Overseeds research and experimentation will answer patients and the health industry expectations to guarantee production sovereignty, proximity of collaborations and certified quality of cultivated products, in direct connection with medical and scientific studies. Patient-driven, the culture of Overseed is based on people, product quality and value creation.
13
Total investors
3
Early stage
10
Mid stage
0
Late stage
2021
Founded

Investors

13 investors
All
Early stage
Mid stage
Late stage
Investor geography3 countries
France
10
Switzerland
2
Czech Republic
1
Investor activity2021–2024 · investors recorded per year
202112022120231202410
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Overseed?
Overseed has 13 investors on record on gritt.io, including 3 early-stage backers, 10 mid-stage.
When did Overseed last raise funding?
The most recent investment in Overseed recorded on gritt.io was in June 2024.
When was Overseed founded?
Overseed was founded in 2021.
What industry is Overseed in?
Overseed operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Overseed based?
Overseed is headquartered in Orléans, France.